Role of VEGF gene variability in longevity: A lesson from the Italian population

Neurobiology of Aging

Volumn 29, Issue 12, 2008, Pages 1917-1922

  Del Bo, Roberto ^a   Ghezzi, Serena ^a   Scarlato, Marina ^a   Albani, Diego ^b   Galimberti, Daniela ^a   Lucca, Ugo ^b   Tettamanti, Mauro ^b   Scarpini, Elio ^a   Forloni, Gianluigi ^b   Bresolin, Nereo ^a,c   Comi, Giacomo Pietro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Aging; Genetic risk factor; Longevity; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; LIFESPAN; LONGEVITY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; FEMALE; GENETIC VARIATION; HUMANS; ITALY; LIFE EXPECTANCY; LONGEVITY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 53849098395     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.05.003     Document Type: Article

References (27)

1. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., and Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 (2006) 916-919
2. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
3. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
4. Chiappelli M., Borroni B., Archetti S., Calabrese E., Corsi M.M., Franceschi M., Padovani A., and Licastro F. VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res. 9 (2006) 485-493
5. Christensen K., Johnson T.E., and Vaupel J.W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7 (2006) 436-448
6. Del Bo R., Comi G.P., Bresolin N., Castelli E., Conti E., Degiuli A., Ausenda C.D., and Scarlato G. The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects. J. Neurol. Sci. 145 (1997) 87-91
7. Del Bo R., Scarlato M., Grezzi S., Martinelli-Boneschi F., Fenoglio C., Galbiati S., Virgilio R., Galimberti D., Galimberti G., Crimi M., Ferrarese C., Scarpini E., Bresolin N., and Comi G.P. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann. Neurol. 57 (2005) 373-380
8. Del Bo R., Scarlato M., Grezzi S., Maestroni A., Sjolind L., Forsblom C., Wessman M., Groop P.H., Comi G.P., Bresolin N., Luzi L., and Zerbini G. VEGF gene variability and type 1 diabetes: evidence for a protective role. Immunogenetics 58 (2006) 107-112
9. Del Bo, R., Scarlato, M., Grezzi, S., Martinelli-Boneschi, F., Corti, S., Locatelli, F., Santoro, D., Pelle, A., Briani, C., Cardini, M., Siciliano, G., Mancuso, M., Murri, L., Bresolin, N., Comi, G.P., 2006b. Absence of angiogenic genes modification in Italian ALS patients. Neurobiol. Aging [epub ahead of print].
10. Fernandez-Santiago R., Sharma M., Mueller J.C., Gohlke H., Illig T., Anneser J., Munch C., Ludolph A., Kamm C., and Gasser T. Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. Neurology 66 (2006) 1929-1931
11. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
12. Greenway M.J., Andersen P.M., Russ C., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K.E., Green A., Acharya K.R., Brown Jr. R.H., and Hardiman O. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 38 (2006) 411-413
13. Jin K.L., Mao X.O., and Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10242-10247
14. Keavney B., McKenzie C., Parish S., Palmer A., Clark S., Youngman L., Delepine M., Lathrop M., Peto R., and Collins R. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355 (2000) 434-442
15. Kim Y., Nam Y.J., and Lee C. Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141 (2006) 332-335
16. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S.L., Wyns S., Thijs V., Andersson J., van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H.S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K.E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P.M., and Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34 (2003) 383-394
17. Panza F., D'Introno A., Colacicco A.M., Capurso C., Capurso S., Kehoe P.G., Capurso A., and Solfrizzi V. Vascular genetic factors and human longevity. Mech. Ageing Dev. 125 (2004) 169-178
18. Rogers M.S., and D'Amato R.J. The effect of genetic diversity on angiogenesis. Exp. Cell. Res. 312 (2006) 561-574
19. Rosenstein J.M., and Krum J.M. New roles for VEGF in nervous tissue-beyond blood vessels. Exp. Neurol. 187 (2004) 246-253
20. Salvioli S., Capri M., Valensin S., Tieri P., Monti D., Ottavini E., and Franceschi C. Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr. Pharm. Des. 12 (2006) 3161-3171
21. Schachter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., and Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6 (1994) 29-32
22. Shahbazi M., Fryer A.A., Pravica V., Brogan I.J., Ramsay H.M., Hutchinson I.V., and Harden P.N. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 13 (2002) 260-264
23. Stevens A., Soden J., Brenchley P.E., Ralph S., and Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res. 63 (2003) 812-816
24. Storkebaum E., and Carmeliet P. VEGF: a critical player in neurodegeneration. J. Clin. Invest. 113 (2004) 14-18
25. Sun F.Y., and Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J. Neurosci. Res. 79 (2005) 180-184
26. Sun Y., Jin K., Xie L., Childs J., Mao X.O., Logvinova A., and Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111 (2003) 1843-1851
27. Tettamanti M., Garrì M.T., Nobili A., Riva E., and Lucca U. Low folate and the risk of cognitive and functional deficits in the very old: the Monzino 80-plus Study. J. Am. College Nutr. 25 (2006) 502-508